Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
12
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| MORGAN STANLEY | 10% Owner | 2 | $0 | $0 | 2017-07-24 |
| Wiley Joseph A. | Director | 3 | $0 | $0 | 2017-07-24 |
| Symonds Jonathan | Director | 3 | $0 | $0 | 2017-07-24 |
| Culverwell Anthony James | Director | 5 | $0 | $0 | 2017-07-24 |
| Fante Rich | Chief Commercial Officer | 3 | $0 | $0 | 2017-07-24 |
| Brennan David R | Director | 4 | $0 | $0 | 2017-07-24 |
| Zook Anthony P. | CEO | 2 | $0 | $0 | 2017-07-24 |
| Banerji Shumeet | Director | 4 | $0 | $0 | 2017-07-24 |
| Hybrid GP Holdings LLC | 10% Owner | 2 | $0 | $0 | 2017-07-24 |
| Russell Lesley | Chief Medical Officer | 2 | $0 | $0 | 2017-07-24 |
| Katzer Charles F | EVP, Global Tech Operations | 3 | $0 | $0 | 2017-07-24 |
| SCHMIDT ROLF D | Director | 5 | $0 | $0 | 2017-07-24 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Symonds Jonathan | Director | D To issuer deriv | 2017-07-24 | 2017-07-26 | 18,289 | — | $0 | 0 | SEC↗ |
| Symonds Jonathan | Director | D To issuer deriv | 2017-07-24 | 2017-07-26 | 14,907 | — | $0 | 0 | SEC↗ |
| Fante Rich | Chief Commercial Officer | D To issuer deriv | 2017-07-24 | 2017-07-26 | 145,750 | — | $0 | 0 | SEC↗ |
| Fante Rich | Chief Commercial Officer | D To issuer deriv | 2017-07-24 | 2017-07-26 | 265,000 | — | $0 | 0 | SEC↗ |
| Culverwell Anthony James | Director | D To issuer deriv | 2017-07-24 | 2017-07-26 | 57,240 | — | $0 | 0 | SEC↗ |
| Culverwell Anthony James | Director | D To issuer deriv | 2017-07-24 | 2017-07-26 | 14,907 | — | $0 | 0 | SEC↗ |
| Culverwell Anthony James | Director | D To issuer deriv | 2017-07-24 | 2017-07-26 | 8,230 | — | $0 | 0 | SEC↗ |
| Culverwell Anthony James | Director | D To issuer deriv | 2017-07-24 | 2017-07-26 | 11,659 | — | $0 | 0 | SEC↗ |
| SCHMIDT ROLF D | Director | D To issuer deriv | 2017-07-24 | 2017-07-26 | 85,608 | — | $0 | 0 | SEC↗ |
| SCHMIDT ROLF D | Director | D To issuer deriv | 2017-07-24 | 2017-07-26 | 11,659 | — | $0 | 0 | SEC↗ |
| SCHMIDT ROLF D | Director | D To issuer deriv | 2017-07-24 | 2017-07-26 | 8,230 | — | $0 | 0 | SEC↗ |
| SCHMIDT ROLF D | Director | D To issuer deriv | 2017-07-24 | 2017-07-26 | 14,907 | — | $0 | 0 | SEC↗ |
| Katzer Charles F | EVP, Global Tech Operations | D To issuer deriv | 2017-07-24 | 2017-07-26 | 50,350 | — | $0 | 0 | SEC↗ |
| Katzer Charles F | EVP, Global Tech Operations | D To issuer deriv | 2017-07-24 | 2017-07-26 | 152,375 | — | $0 | 0 | SEC↗ |
| Russell Lesley | Chief Medical Officer | D To issuer deriv | 2017-07-24 | 2017-07-26 | 185,500 | — | $0 | 0 | SEC↗ |
| Banerji Shumeet | Director | D To issuer deriv | 2017-07-24 | 2017-07-26 | 8,230 | — | $0 | 0 | SEC↗ |
| Banerji Shumeet | Director | D To issuer deriv | 2017-07-24 | 2017-07-26 | 14,907 | — | $0 | 0 | SEC↗ |
| Banerji Shumeet | Director | D To issuer deriv | 2017-07-24 | 2017-07-26 | 11,659 | — | $0 | 0 | SEC↗ |
| Wiley Joseph A. | Director | D To issuer deriv | 2017-07-24 | 2017-07-26 | 8,916 | — | $0 | 0 | SEC↗ |
| Wiley Joseph A. | Director | D To issuer deriv | 2017-07-24 | 2017-07-26 | 14,907 | — | $0 | 0 | SEC↗ |
| Wiley Joseph A. | Director | D To issuer deriv | 2017-07-24 | 2017-07-26 | 8,230 | — | $0 | 0 | SEC↗ |
| Zook Anthony P. | CEO | D To issuer deriv | 2017-07-24 | 2017-07-26 | 132,500 | — | $0 | 0 | SEC↗ |
| Brennan David R | Director | D To issuer deriv | 2017-07-24 | 2017-07-26 | 11,659 | — | $0 | 0 | SEC↗ |
| Brennan David R | Director | D To issuer deriv | 2017-07-24 | 2017-07-26 | 14,907 | — | $0 | 0 | SEC↗ |
| Brennan David R | Director | D To issuer deriv | 2017-07-24 | 2017-07-26 | 8,230 | — | $0 | 0 | SEC↗ |
| MORGAN STANLEY | 10% Owner | E Expire deriv | 2017-07-24 | 2017-07-28 | 795,980 | — | $0 | 0 | SEC↗ |
| Hybrid GP Holdings LLC | 10% Owner | E Expire deriv | 2017-07-24 | 2017-08-07 | 929,156 | — | $0 | 0 | SEC↗ |
| Symonds Jonathan | Director | D To issuer | 2017-07-24 | 2017-07-26 | 525,446 | — | $0 | 0 | SEC↗ |
| Fante Rich | Chief Commercial Officer | D To issuer | 2017-07-24 | 2017-07-26 | 202,630 | — | $0 | 0 | SEC↗ |
| Culverwell Anthony James | Director | D To issuer | 2017-07-24 | 2017-07-26 | 291,566 | — | $0 | 0 | SEC↗ |
| SCHMIDT ROLF D | Director | D To issuer | 2017-07-24 | 2017-07-26 | 386,587 | — | $0 | 0 | SEC↗ |
| Katzer Charles F | EVP, Global Tech Operations | D To issuer | 2017-07-24 | 2017-07-26 | 163,100 | — | $0 | 0 | SEC↗ |
| Russell Lesley | Chief Medical Officer | D To issuer | 2017-07-24 | 2017-07-26 | 187,142 | — | $0 | 0 | SEC↗ |
| Banerji Shumeet | Director | D To issuer | 2017-07-24 | 2017-07-26 | 308,660 | — | $0 | 0 | SEC↗ |
| Zook Anthony P. | CEO | D To issuer | 2017-07-24 | 2017-07-26 | 682,396 | — | $0 | 0 | SEC↗ |
| Brennan David R | Director | D To issuer | 2017-07-24 | 2017-07-26 | 237,440 | — | $0 | 0 | SEC↗ |
| MORGAN STANLEY | 10% Owner | S Sale | 2017-07-24 | 2017-07-28 | 3,365,978 | — | $0 | 0 | SEC↗ |
| Hybrid GP Holdings LLC | 10% Owner | S Sale | 2017-07-24 | 2017-08-07 | 4,085,469 | — | $0 | 0 | SEC↗ |